Motus GI Holdings, Inc. (MOTS)
$0.475
+0.00 (+0.96%)
Rating:
Recommendation:
Neutral
| Symbol | MOTS |
|---|---|
| Price | $0.475 |
| Beta | 1.897 |
| Volume Avg. | 0.06M |
| Market Cap | 2.799M |
| Shares () | - |
| 52 Week Range | 0.43-4.81 |
| 1y Target Est | - |
| DCF Unlevered | MOTS DCF -> | |
|---|---|---|
| DCF Levered | MOTS LDCF -> | |
| ROE | -3915.32% | Strong Sell |
| ROA | -140.98% | Strong Sell |
| Operating Margin | - | |
| Debt / Equity | -1052.34% | Strong Sell |
| P/E | -0.15 | Neutral |
| P/B | -3.73 | Strong Sell |
Latest MOTS news
About
Download (Excel)Motus GI Holdings, Inc., a medical technology company, develops Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedure. The company was incorporated in 2016 and is based in Fort Lauderdale, Florida.